Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
alder biopharmaceutical
allergan
american academy of neurology
amgen
atogepant
biohaven
biotech
bob azelby
boston blog main
boston top stories
botox
boulder/denver blog main
boulder/denver top stories
brian abrahams
calcitonin gene-related peptide
clinical trials
detroit blog main
detroit top stories
drugs
eli lilly
eptinezumab
erenumab
fda
fremanezumab
galcanezumab
impel neuropharma
indiana blog main
indiana top stories
jefferies
lasmiditan
life sciences
marc goodman
medical device
migraine
migraine research foundation
national
national blog main
national top stories
new york blog main
new york top stories
What
oral
2
×
potential
2
×
active
advisory
approval
arguments
basically
better
big
class
cold
commercialized
common
companies
competitors
congestion
decades
drug
drugs
fda
fda’s
florida
getty
images
ingredient
joe
key
make
medications
medicine
meeting
member
miami
migraine
neuro
new
panel
phenylephrine
photo
pictured
Language
unset
Current search:
oral
×
potential
×
@theverge.com
9 months ago
A key cold medicine ingredient is basically worthless
@xconomy.com
5 years ago
At Big Neuro Meeting, Migraine Drug Competitors to Make Oral Arguments